SciELO - Scientific Electronic Library Online

 
vol.91 número1Análisis del coste directo de la atención médica y quirúrgica del cáncer de mama. Estudio comparativo entre etapas temprana y tardía en tercer nivel de atenciónExactitud diagnóstica en el cáncer de esófago localizado. Estudio observacional retrospectivo índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • No hay artículos similaresSimilares en SciELO

Compartir


Cirugía y cirujanos

versión On-line ISSN 2444-054Xversión impresa ISSN 0009-7411

Resumen

LOPEZ-CONTRERAS, José E. et al. Incidence and factors associated with early and late adverse reactions after the first dose of Pfizer-BioNTech vaccine among healthcare workers. Cir. cir. [online]. 2023, vol.91, n.1, pp.34-41.  Epub 16-Mayo-2023. ISSN 2444-054X.  https://doi.org/10.24875/ciru.21000749.

Objective:

To determine the incidence of adverse reactions (AR) after the first dose of Pfizer-BioNTech vaccine, and to identify some factors associated with AR.

Method:

A retrospective cohort study was conducted. Data were obtained through an epidemiological survey answered online. Multivariate analyses were performed to identify factors associated with early (< 2 h) and late (≥ 2 h) AR.

Results:

A total of 2295 health care workers were included; in them, the cumulative incidence of AR was 18.2% (95% confidence interval: 16.6-19.8), where the majority were late (78.2%). The associated factors that increased the risk of early AR were being female (odds ratio [OR]: 2.23, p = 0.002) and belonging to the medical staff (OR: 1.56; p = 0.041). In late AR were being female (OR: 1.94; p < 0.0001); on the other hand, diabetes (OR: 0.46; p = 0.021), asthma (OR: 0.53; p = 0.040) and smoking (OR: 0.44, p = 0.002) were inversely associated factors. Interestingly, history of COVID-19 was not associated with either early or late AR.

Conclusions:

The risk of presenting some type of AR due to the Pfizer-BioNTech vaccine in health care workers is < 20%.

Palabras llave : Adverse reactions; BNT162b2 vaccine; COVID-19; Health care workers.

        · resumen en Español     · texto en Español